Private Travel & Routine Vaccination Prices | Hampstead Heath Pharmacy, London NW3

*Price includes consultation & private prescription

We provide acetazolamide to prevent altitude illness for suitable individuals, subject to consultation. This service will help you effectively prevent Altitude Sickness, ensuring you can safely enjoy your holiday.

Altitude illness occurs when ascending rapidly to high altitudes (typically above 2,500m). Severe altitude illness is a life-threatening condition.

For more detailed information, read the CDC Yellow Book on High-Altitude Travel and Altitude Illness.

TD is the most common health problem affecting overseas travellers. Our service will help you effectively prevent and manage Travellers’ Diarrhoea (TD) so you can fully enjoy your holiday.

Stand-by antibiotics, such as azithromycin, are strictly for those at high risk of severe illness or visiting high-risk areas, supplied following a consultation.

Note: Studies of probiotics to prevent TD are ongoing, but data are insufficient to recommend their use.

Learn more via the CDC Guidelines on Travellers' Diarrhoea.

For further guidance, visit the TravelHealthPro Factsheet on Malaria.

We administer BCG AJV, the only BCG vaccine licensed in the UK and used by the NHS.
A Mantoux test is required prior to BCG for individuals aged 6+, or children under 6 with prolonged stays in high-risk countries.

For more details, visit our dedicated BCG & TB Testing page.

Dose Intervals: The standard schedule is two doses administered 4 to 8 weeks apart. The absolute minimum licensed interval between the first and second dose is 4 weeks.

2026 NHS Policy: Children will receive a combined MMRV vaccine on the NHS. Eligibility varies heavily by birthdate. Children born on or before 31 Dec 2019 are NOT eligible and can only access varicella vaccination privately. A single MMRV catch-up dose will be offered on the NHS to children born between 1 January 2020 and 31 August 2022 (from November 2026 to March 2028), provided they have not had chickenpox or two doses of varicella vaccine.

Read more on our dedicated Chickenpox vaccine page.

We provide Vimkonya®, a non-live chikungunya vaccine. Traditional mosquito avoidance methods alone are not necessarily sufficient against day-biting Aedes mosquitoes.

Find more details on the TravelHealthPro Factsheet on Chikungunya.

In clinical trials, the cholera vaccine (Dukoral) has shown efficacy against Enterotoxigenic Escherichia coli (ETEC), a common cause of travellers’ diarrhoea. Please note, Dukoral is prescribed off-label for this indication. Strict food and water hygiene remain essential.

Learn more via the TravelHealthPro Factsheet on Cholera.

The Green Book notes that, exceptionally, Qdenga® may be considered for individuals who have not had dengue in the past, where the potential benefits are judged to outweigh the risks after individual clinical assessment.

For more details, visit the TravelHealthPro Factsheet on Dengue.

We provide a range of combination vaccines tailored to different age groups and travel or occupational requirements:

• 5-in-1 (Infanrix-IPV+Hib): £128
  Suitable from 8 weeks to 3 years of age. This is interchangeable with the 6-in-1 vaccine (Infanrix hexa or Vaxelis), where hepatitis B can be given separately.
• 4-in-1 [Repevax = Diphtheria, Tetanus, Pertussis and Polio = Tdap-IPV]: £100
  Suitable for those 3 years of age and above.
• 3-in-1 [Adacel = Diphtheria, Tetanus & Pertussis = Tdap]: £100
  Suitable for those 4 years of age and above.

Tdap or Tdap-IPV are recommended for visa requirements, pregnant women (ideally between 16 and 32 weeks to maximise protection for the baby), or close family members visiting a newborn.

Private Flu Vaccinations

Influenza has been described as the most frequent vaccine preventable infection among travellers to tropical and subtropical countries.

NHS Flu Vaccinations

Incomplete courses: If you received one dose years ago, you do not need to restart the course. A single dose now will complete it.

For more details, visit the TravelHealthPro Factsheet on Hepatitis A.

Schedules: Standard (0, 1, 6 months) or Rapid (0, 7, 21 days & 12 months) used when time is short prior to travel.

For more details, visit the TravelHealthPro Factsheet on Hepatitis B.

Why Choose Ambirix?

• Fewer Injections: It simplifies long-term protection, requiring only two injections instead of five (if giving Hep A & Hep B separately).
• Cost-Effective: Works out less expensive overall than individual course bookings.

Dose Timings & Delays

• The second dose should ideally be given within 6–12 months after the first dose.
• Delayed Doses: Although second doses delayed beyond this window fall outside the product licence, evidence shows that a delayed second dose still significantly boosts the immune response. There is no maximum interval requiring you to restart a course.

Read the official guidance for Hepatitis A and Hepatitis B.

Dosing Schedules

• 2-Dose Schedule (NHS Recommended for Adults & Adolescents): Given at 0 and 6 months (minimum 6 months apart). While traditionally licensed primarily for ages 9–14, updated NHS and JCVI guidance now recommends this two-dose schedule for adults as well, as it provides highly effective protection.
• Standard 3-Dose Schedule: Given at 0, 2, and 6 months.
  • Minimum interval between Dose 1 & 2: 1 month
  • Minimum interval between Dose 2 & 3: 3 months
  • All three doses must be given within a 1-year period.

Find out more on our dedicated HPV vaccination page.

Minimum Dose Intervals

• Standard schedule: 0 & 28 days.
• Rapid schedule: 0 & 7 days. This is licensed for adults (18-65 years) as per the Green Book, and is ideal for travellers leaving in less than one month.

Unlicensed rapid schedule use: For children (from two months of age) and adults aged 65 years and older, the rapid schedule is not licensed due to a lack of data. However, it can be used in circumstances where there is genuinely insufficient time to complete the standard schedule prior to travel. There are no data to suggest that the rapid schedule would be harmful for these travellers.

For more details, visit the TravelHealthPro Factsheet on Japanese Encephalitis.

We supply Adaflex 3mg tablets (30 tablets), used for the short-term treatment of jet lag in adults. This is a medical-grade melatonin.

For additional strategies on managing circadian rhythms, visit the CDC Yellow Book: Jet Lag Disorder.

Meningococcal disease, including meningitis and septicaemia, can occur at any age, which is why many parents choose to secure protection for their children as early as possible.

We offer the MenACWY vaccine privately, with Nimenrix® available from 6 weeks of age and MenQuadfi® from 12 months — well ahead of the NHS routine offer at age 14.

Are Boosters Required?

In the UK, MenACWY is routinely offered to adolescents around age 14 (school Year 9), with catch-up available up to the 25th birthday.

Waning Immunity & Self-Pay Boosters

Immunogenicity data shows that antibody levels wane within 3–5 years of a single MenACWY dose. This waning is substantially more pronounced in adults vaccinated later in life without prior childhood priming. For those paying privately, we would consider a booster particularly relevant for:

• Travellers: Individuals heading to the meningitis belt or Saudi Arabia whose last dose was more than 5 years ago.
• Unprimed Adults: Adults vaccinated for the first time, in whom waning is faster than in primed adolescents.
• University Students: Young adults whose adolescent dose was given at 13–14 and who are now 18+, approaching 5 years post-vaccination.
• Clinical Risk Factors: Anyone with complement deficiency, asplenia, or complement inhibitor use (US CDC guidance recommends boosters every 5 years for these groups).

Certification is available if required at no extra charge (e.g., for Hajj/Umrah).

Are Boosters Required?

We use UK-licensed MenB vaccines, with schedules tailored to age and clinical circumstances. Note: The booster dose should be the same brand as the primary course (the first two doses).

Key Groups to Consider for a Booster

• University Students (Primary Focus): Teenagers and young adults entering higher education or living in shared accommodation, where the risk of transmission peaks significantly.
• Occupational Exposure: Laboratory staff working with Neisseria meningitidis (UK guidance recommends MenB boosters every 5 years).
• Clinical Risk Factors: Individuals with specific underlying health conditions, such as complement deficiency or asplenia.

If you are travelling to an area where measles is common or currently spreading, please ensure you are fully up to date with your standard UK routine vaccinations before departure.

Early Vaccination for Babies

Intervals with other vaccines

• Yellow Fever & MMR: Must be 4 weeks apart. In urgent circumstances where protection is needed rapidly, both may be given at any interval; an additional dose of MMR should then be considered (Green Book Ch.35).
• Chickenpox & MMR: If not given on same day, must be 4 weeks apart.
• Mantoux & MMR: Delay MMR until skin test is read.

Pneumococcal pneumonia is a potentially serious bacterial lung disease. We offer multiple vaccine options based on age and previous NHS immunisations:

• Prevenar 13 (PCV13): £109. Suitable from 6 weeks of age. Part of the current NHS childhood vaccination schedule.
• Prevenar 20 (PCV20): £117. Suitable from 6 weeks of age.
• Capvaxive (PCV21): £155.80. Suitable from 18 years of age.

For more detailed information regarding immunisation timings, view the UKHSA Complete Routine Immunisation Schedule.

Intradermal (ID) Injection: £55 per dose

The 1-week, 4-dose regimen (MHRA approved 2024 / WHO endorsed). Given as 4 doses over 2 appointments with a 7-day interval (1 dose in both arms per visit).

Intramuscular (IM) Injection: £110 per dose

Conventional (0, 7, 21 days) or Rapid (0, 3, 7 & 365 days) schedules available.

Rabies Booster Guidance

Pre-exposure (travellers and at-risk occupations): After completing a full primary course, most healthy travellers do not require routine booster doses. In the UK, current guidance is to base any future boosters on individual risk and, where relevant, antibody testing rather than automatic time-based boosters.

Ongoing high-risk exposure: People with continued high risk (e.g. certain laboratory staff, bat handlers) may need periodic serology and boosters if antibody levels fall below recommended thresholds, as advised by occupational health or a specialist clinic.

Post-exposure: Booster (or completion) doses after a bite or significant exposure are given according to national post-exposure protocols, which depend on the person’s previous vaccination history, the type of exposure and the animal involved.

Private Adult & Maternal RSV Vaccination (£240 per dose)

Timing & Revaccination

• Best Time to Vaccinate: Late summer or early autumn, prior to the winter RSV peak.
• Booster Guidance: Because a single dose provides multi-season protection, annual boosters are not currently required. Revaccination may be considered after 24 to 36 months as antibody levels naturally wane over time. We recommend booking a consultation to discuss your specific needs.

For a full list of side effects, please see the official Abrysvo patient leaflet (PIL).

NHS RSV Vaccination

The NHS offers a free RSV vaccine to pregnant women (from 28 weeks), all adults aged 75 and over, and all individuals living in care homes for older adults. If you fall into these categories, please check eligibility and book via your GP or the NHS website.

Protect Your Baby Against RSV

Give your baby an extra layer of protection against Respiratory Syncytial Virus (RSV) when they need it most.

What is RSV?

RSV is a highly contagious virus that causes respiratory infections in babies. It is most common during the winter virus months. While it can initially look like a mild, cold-like illness, it can spread and worsen, leading to severe lung illnesses such as bronchiolitis or pneumonia. RSV is hard to predict, and even healthy, full-term babies can get very sick. RSV causes more hospitalisations in children under 5 than influenza in the UK, with RSV hospitalisation rates in infants estimated to be significantly higher than those for flu.

How Beyfortus Works

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by RSV. It is intended for newborns and babies under one year of age born during or entering their first RSV season. Children up to 24 months who remain at risk through their second season may also receive it.

• It is not a vaccine: While vaccines help teach the body to make its own antibodies, Beyfortus directly provides your baby with ready-made preventive antibodies to help their young immune system fight serious RSV.
• Immediate and lasting protection: It works right away and helps protect your baby for at least five to six months, which covers an entire RSV season.
• Proven foundation: The concept of providing babies with ready-made RSV antibodies (passive immunisation) has been used for over 25 years, with palivizumab (the predecessor antibody) first approved in 1999. Beyfortus represents the next generation of this approach — more effective and requiring only a single seasonal dose.

Efficacy & Protection

Please review the UK Official Patient Leaflet (PIL) for more clinical information.

For additional details regarding childhood immunisations, review the Complete Routine Immunisation Schedule.

We utilise the new, highly effective non-live shingles vaccine (Shingrix). No matter how healthy you feel, your immune system declines with age, putting you at an increased risk for shingles. 1 in 3 people will get shingles in their lifetime.

For more detailed information, please read our dedicated Shingles vaccine page.

Dose Intervals

• Standard Schedule: Dose 1 on your elected date, Dose 2 at 1 to 3 months after the first dose, and Dose 3 at 5 to 12 months after the second dose.
• Rapid Schedule (short-notice travel): Dose 2 can be given 14 days after Dose 1. Dose 3 is still given 5 to 12 months after the second dose. The minimum licensed interval between Dose 1 and Dose 2 is 14 days.

Booster Doses

• First booster: 3 years after your third (completing) dose.
• Subsequent boosters (ages 1 to 59): Every 5 years after the first booster.
• Subsequent boosters (age 60 and over): Every 3 years — all booster doses in this age group should not exceed a 3-year interval.

The top 7 countries with the highest prevalence of Tick-borne encephalitis are Lithuania, Latvia, Estonia, the Czech Republic, Slovenia, Sweden, and Austria.

For more details, visit the TravelHealthPro Factsheet on TBE.

• Oral Capsules: A live vaccine given as 3 doses on alternate days (suitable from 5 years of age).
• Injection: A single-dose, non-live vaccine (suitable from 2 years of age).

We can vaccinate children between the ages of 12 months and two years off-label if following a detailed risk assessment the risk of typhoid fever is considered high. Immunisation is not recommended for children under one year of age. When children are too young to benefit fully from typhoid vaccination, scrupulous attention to personal, food and water hygiene measures should be exercised by the caregiver.

Find out more via the TravelHealthPro Factsheet on Typhoid.

Our comprehensive weight management programme includes unlimited 1-to-1 coaching & support from our clinical team. Learn more here.

About the Disease & Protection

• The Risk: A viral disease transmitted by mosquitoes, ranging from mild to severe. There is no treatment; care focuses solely on symptom management.
• Prevention: Strict mosquito bite avoidance and vaccination are strongly recommended for travellers visiting risk areas.

Certification & Requirements

• Mandatory Entry: Under International Health Regulations, a certificate may be a mandatory entry requirement for certain countries—even if the actual disease risk is low for your specific itinerary.
• Authorised Centres: The vaccine is exclusively available at designated UK Yellow Fever Vaccination Centres (YFVCs), like Hampstead Heath Pharmacy.

For more information, please review the TravelHealthPro Factsheet on Yellow Fever.

Certificate Guidelines

• Standard Validity: Existing International Certificates of Vaccination or Prophylaxis (ICVP) with a 10-year validity are acceptable under International Health Regulations and do not routinely need reissuing.
• Replacements: We can issue a replacement ICVP if your original is genuinely lost, badly damaged, or subject to a verified name change, provided an accurate medical record of the previous vaccination can be seen.
• Lost Records: If you have lost your certificate and do not possess the official dates and batch numbers, the only legally acceptable approach for immigration authorities is to repeat the vaccination.
• Medical Exemptions: We can issue medical letters of exemption from the ICVP when clinically appropriate.

For additional details, visit the NaTHNaC Factsheet on the ICVP or check the NaTHNaC Yellow Fever Vaccine Recommendation Maps.